{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-25-001353","form_type":"8-K","ticker":"PTHS","cik":"0001919246","company_name":"Pelthos Therapeutics Inc.","filed_at":"2025-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.589072+00:00","generated_at":"2026-05-17T12:06:36.335580+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"Pelthos Therapeutics completes merger, launches ZELSUVMI, hires 50 sales managers","bullets":["Completed merger with Channel Therapeutics and closed $50.1M private placement on July 1, 2025.","Launched ZELSUVMI (berdazimer) on July 10, 2025, first at-home FDA-approved treatment for molluscum contagiosum.","Built commercial team of 90+ employees including 50 territory sales managers; early orders and prescriptions meeting/exceeding expectations.","In advanced discussions to acquire a second FDA-approved pediatric infectious disease product.","Public float ~600k shares; market cap ~$55M (~$165M fully diluted); lockup on Series A Preferred through Dec 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-25-001353","json":"https://secwatch.observer/filing/0001753926-25-001353.json","markdown":"https://secwatch.observer/filing/0001753926-25-001353.md","text":"https://secwatch.observer/filing/0001753926-25-001353.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1919246/000175392625001353/0001753926-25-001353-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1919246/000175392625001353/g084926_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:06:36.335580+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}